The FASEB Journal — FASEB stands for the Federation of American Societies for Experimental Biology — is retracting a 15-year-old paper without the consent of all of the authors, despite what seem like valiant attempts to figure out exactly what went wrong.
Here’s the notice for the University of Bern-University of Urbino paper:
Continue reading FASEB J retracts 15-year-old study after author comes forward, but universities decline to investigate
We try to avoid straying beyond science on this blog, but sometimes — as in the case of This American Life, which not long ago had to retract a segment featuring Mike Daisey that had been critical of the conditions in a Chinese factory linked to Apple — we can’t help ourselves. Like now.
A retraction might be the next tune for one Timothy Michael Poe, who has been a contestant on America’s Got Talent. According to the Associated Press, the aspiring country singer told the show’s judges that:
Continue reading Is a retraction in the works for America’s Got Talent star?
Last week, we wrote about a correction of a heavily criticized paper in The Lancet by the Millennium Villages Project, a large aid program. Paul Pronyk, director of monitoring and evaluation at Columbia University’s Center for Global Health and Economic Development, which runs the Project, left his job shortly after writing an explanatory letter that accompanied the correction.
That correction had come after a letter to The Lancet, but also after Nature had raised issues in an editorial. Nature’s editorial concluded: Continue reading Former Millennium Villages Project staffer responds to critical Nature editorial
We have an update on the case of a University of Utah lab that retracted two Cell Metabolism papers last month after a fired lab technician disposed of two lab notebooks without permission. The team has now corrected two other papers, one in Blood and the other in the Journal of Clinical Investigation.
Here’s the notice from Blood: Continue reading Two new corrections for Utah group that retracted two Cell Metabolism papers for missing notebooks
The other day we brought you the story (well, not quite a STORY) of a group of researchers who had to retract a paper in the Journal of Computational Chemistry because of a “computation error.” We still don’t know what that means.
That was fresh in our minds when we came across the following retraction notice in the Journal of Obstetrics and Gynaecology Research: Continue reading Premature delivery? Paper on rapid assay for ruptured placenta pulled for “mishandling” of tests
If you’re going to publish in the Journal of Computational Chemistry, it probably makes sense to have one’s computer tuned up for the task.
Or else you might wind up like a group of researchers in China who had to endure this misfortune: Continue reading Computational chem journal retracts article for, um, computation error
One of the biggest stories so far out of the American Society of Clinical Oncology (ASCO) meeting that just ended in Chicago was that of T-DM1, which, according to Ivan’s Reuters colleagues, “extended the length of time breast cancer patients lived without their disease getting worse.” (The news was even the subject of an embargo break.)
The widely-hailed study of Roche’s drug was led by Duke’s Kimberly Blackwell, who told The New York Times: Continue reading Lead author of major breast cancer study announced at ASCO co-authored two corrected papers with Anil Potti
Dipak Das, the UConn researcher whom the university earlier ths year found to have fabricated or falsified data more than 100 times, has four more retractions to his name.
The notices appear in the June 1, 2012 issue of the American Journal of Physiology: Heart and Circulatory Physiology, and suggest that Das was not all that cooperative: Continue reading Retraction count for resveratrol researcher Dipak Das rises to 12
When the first sentence of a science paper reads like this, you might think you’re in for quite a ride:
Jumping out of an airplane may seem like a crazy and scary thing to do, but for a skydiver it is a fun and exciting experience.
Unfortunately for the authors of an earlier version of that paper comparing gamblers and skydivers, published in 2011 in the Scandinavian Journal of Psychology, the ride was short-lived, according to a retraction notice just published: Continue reading Psychologists take a gamble on using data about risky behavior, and are forced to retract a paper
The European Journal of Medicinal Chemistry has published a curious retraction notice for a paper in its February 2012 issue from a group of Indian scientists.
The abstract of the article,”Proton-pumping-ATPase-targeted antifungal activity of cinnamaldehyde based sulfonyl tetrazoles,” is still available on Medline:
Here’s what the abstract of the paper said about the study: Continue reading ‘Molecular characterization’ errors lead to retraction from medicinal chemistry journal